1673-422X
2013 Issue 12
Abnormal glycometabolism in tumor cells
MENG Xiang-jun;,SUN Jie;
MENG Xiang-jun;,SUN Jie;
..............page:883-885
Resistant mechanisms of doxorubicin
XIAN Zhi-rong;,ZHANG Guo-jun;
XIAN Zhi-rong;,ZHANG Guo-jun;
..............page:886-889
Mechanisms and reversal strategies of tumor multidrug resistance
LIU Shu-ye;,WU Jing;,YANG Rui;
LIU Shu-ye;,WU Jing;,YANG Rui;
..............page:889-892
Antitumor mechanism of kaempferol
FU Cheng-rui;,LI Bao-sheng;
FU Cheng-rui;,LI Bao-sheng;
..............page:892-895
Y-box-binding protein 1 and epithelial-mesenchymal transition
JIN Zhi-ming;,YAN Xue-bing;,ZHU Qing-chao;
JIN Zhi-ming;,YAN Xue-bing;,ZHU Qing-chao;
..............page:896-899
EMT mediated cancer stemness and tumor
DENG Chun-yan;,HUANG Jian-ming;,LI Tao;,TAN Xiao-qin;
DENG Chun-yan;,HUANG Jian-ming;,LI Tao;,TAN Xiao-qin;
..............page:899-902
Roles of SIRT1 in tumorigenesis and tumor progression
FU De-qiang;,WU Wen-yi;,ZHANG Li-ting;
FU De-qiang;,WU Wen-yi;,ZHANG Li-ting;
..............page:902-904
ZHX2 and cancer
FU Shi-jie;,GUO Qing-he;
FU Shi-jie;,GUO Qing-he;
..............page:905-907
Functions of cytokine induced killer cells in oncotherapy
GAO Meng;,YUN Sheng;
GAO Meng;,YUN Sheng;
..............page:908-911
Nimotuzumab in the treatment of solid tumors
LIU Qiao-hong;,SUN Yu-ping;,WANG Lin-lin;
LIU Qiao-hong;,SUN Yu-ping;,WANG Lin-lin;
..............page:911-914
Research progress of esophageal cancer mouse models
CHENG Yu-feng;,MA Wei;,WANG Kai;
CHENG Yu-feng;,MA Wei;,WANG Kai;
..............page:915-918
Stereotactic body radiotherapy for peripheral non-small cell lung cancer
DU Ze-dong;,LI Chang-lin;,WANG Wei-lin;
DU Ze-dong;,LI Chang-lin;,WANG Wei-lin;
..............page:918-920
Clinicopathological features and therapies of elderly women with triple-negative breast cancer
GAO jing;
GAO jing;
..............page:921-923
Epithelial-mesenchymal transition and gastric cancer
LI Ji-kun;,LIU Li-min;
LI Ji-kun;,LIU Li-min;
..............page:924-926
NOD2 gene and primary hepatocellular carcinoma
LIANG Ning;,QIAO Li-li;,XIE Jian;,ZHANG Jian-dong;
LIANG Ning;,QIAO Li-li;,XIE Jian;,ZHANG Jian-dong;
..............page:927-929
CRD-BP and β-TrCP in colorectal cancer
CHENG Li;,JIA Dan-dan;,QI Wen-juan;,ZHOU Chang-jiang;
CHENG Li;,JIA Dan-dan;,QI Wen-juan;,ZHOU Chang-jiang;
..............page:930-932
Clinical applications of raltitrexed in colorectal cancer
HU Bing;,PENG Deng-fu;,WANG Yong;
HU Bing;,PENG Deng-fu;,WANG Yong;
..............page:933-935
Expressions and clinical significances of microRNA-126 and microRNA-7 in esophageal squamous cell carcinoma
LING Zhi-qiang;,MAO Wei-min;,WANG Jiang-feng;
LING Zhi-qiang;,MAO Wei-min;,WANG Jiang-feng;
..............page:936-940
Comparative study of 18F-FDG PET/CT and 99Tcm-MDP bone scintigraphy in detecting multiple myeloma bone destruction
GUO Hui-min;,KONG Xiang-hui;,L(U) Kuan;,WU Zhi-xing;,ZHANG Ke;
GUO Hui-min;,KONG Xiang-hui;,L(U) Kuan;,WU Zhi-xing;,ZHANG Ke;
..............page:940-944
zhong zu ren xue guan nei pi yi zhi su lian he shun bo bai xi bao jie su -2 zhi liao shi guan ai xiong qiang ji ye de liao xiao guan cha
guo ni ;, he zuo ;
guo ni ;, he zuo ;
..............page:945-946
Analysis of Chinese oncology papers included by SCI in 2012
MA Xia;,SUN Na;,YANG Wen-yan;,ZHANG Jing-jing;,ZHEN Tian-min;
MA Xia;,SUN Na;,YANG Wen-yan;,ZHANG Jing-jing;,ZHEN Tian-min;
..............page:947-951
Comparative analysis of Chinese oncology papers included by CBM and SCI in 2012
HAN Zhi-yan;,LI Jing-li;,MA Xia;,SUN Na;,YANG Wen-yan;,ZHANG Jing-jing;,ZHEN Tian-min;
HAN Zhi-yan;,LI Jing-li;,MA Xia;,SUN Na;,YANG Wen-yan;,ZHANG Jing-jing;,ZHEN Tian-min;
..............page:952-954